Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Astellas Pharma US Release: CRESEMBA (Isavuconazonium Sulfate) Data To Be Presented At The European Congress Of Clinical Microbiology And Infectious Diseases 4/24/2015 12:30:24 PM
MedDay Reports Positive Pivotal Phase III Study Results With MD1003 In Patients With Progressive Multiple Sclerosis 4/24/2015 10:53:00 AM
Aerie (AERI) Freefalls Aftermarket as Rhopressa Fails Phase III Study 4/23/2015 8:29:33 PM
Aerie (AERI) Reports Initial Rhopressa Phase III Efficacy Results 4/24/2015 5:49:59 AM
Actavis (ACT) Announces Topline Phase 3 Clinical Trial Results For Single-Dose DALVANCE (Dalbavancin) In The Treatment Of ABSSSI 4/24/2015 10:14:17 AM
GENFIT (ALGFT): New Proof Of Efficacy Of Gft505 In Nash And Positive Expert Opinion 4/24/2015 8:45:43 AM
GlaxoSmithKline (GSK)'s Malaria Vaccine Phase III Study Containing Agenus’ QS-21 Published In The Lancet 4/24/2015 7:29:41 AM
BioMarin (BMRN) Presents Data On Duchenne Muscular Dystrophy At The 67th American Academy of Neurology Annual Meeting 4/23/2015 7:07:56 PM
BioTie Therapies Corp. Provides Update On Tozadenant Phase 3 Program 4/23/2015 9:15:33 AM
Janssen Announces SVR12 Rates With Twelve Weeks Of Treatment With All-Oral, Once-Daily Regimen Of Simeprevir Plus Sofosbuvir In Genotype 1 HCV Patients With And Without Cirrhosis 4/23/2015 11:33:48 AM
CorMedix (CRMD) Presents Data from Neutrolin Post Marketing Surveillance Study At Two Medical Conferences 4/23/2015 11:10:41 AM
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Data From ISIS-TTR Rx In Patients With TTR Amyloidosis 4/23/2015 10:59:11 AM
GW Pharmaceuticals (GWPH) Announces New Physician Reports Of Epidiolex Treatment Effect In Children And Young Adults With Treatment-Resistant Epilepsy 4/23/2015 10:43:28 AM
Janssen Sciences Ireland UC Announces SVR12 Rates With Twelve Weeks Of Treatment With All-Oral, Once-Daily Regimen Of Simeprevir ? Plus Sofosbuvir ? In Genotype 1 HCV Patients With And Without Cirrhosis 4/23/2015 8:44:15 AM
Effect Of Genzyme (GENZ)’s Multiple Sclerosis Treatment Lemtrada (Alemtuzumab) On Slowing Brain Atrophy And MRI Lesion Activity Maintained Through Four Years 4/23/2015 8:42:28 AM
1234567
//-->